Centessa Pharmaceuticals PLC ADR (CNTA)vsInsmed Inc (INSM)
CNTA
Centessa Pharmaceuticals PLC ADR
$28.22
+1.18%
HEALTHCARE · Cap: $4.07B
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 3943% more annual revenue ($606.42M vs $15.00M). CNTA leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
CNTA
Avoid24
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
Trading at 12.6x book value
0.0% revenue growth
0.0% earnings growth
0.0% margin — thin
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CNTA
CNTA has a balanced fundamental profile.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : CNTA
The primary concerns for CNTA are Price/Book, Revenue Growth, EPS Growth.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
CNTA profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
CNTA carries more volatility with a beta of 1.55 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
CNTA generates stronger free cash flow (-59M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centessa Pharmaceuticals PLC ADR
HEALTHCARE · BIOTECHNOLOGY · USA
Centessa Pharmaceuticals Limited, a pharmaceutical company, develops and delivers drugs that change and improve the lives of patients. The company is headquartered in Cambridge, the United Kingdom.
Visit Website →Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?